世界のICU（集中治療室）における急性腎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global ICU-acquired Acute Kidney Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4343
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ICU（集中治療室）における急性腎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腎前部、内在性腎、腎後部）、用途別市場規模（公立病院、私立病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ICU（集中治療室）における急性腎治療の市場動向
・企業の競争状況、市場シェア
・ICU（集中治療室）における急性腎治療の種類別市場規模と予測2016-2027（腎前部、内在性腎、腎後部）
・ICU（集中治療室）における急性腎治療の用途別市場規模と予測2016-2027（公立病院、私立病院）
・ICU（集中治療室）における急性腎治療の北米市場規模2016-2027（アメリカ、カナダ）
・ICU（集中治療室）における急性腎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ICU（集中治療室）における急性腎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ICU（集中治療室）における急性腎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ICU（集中治療室）における急性腎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Quark Pharmaceuticals、Fresenius Medical Care、B. Braun、Baxter international、Angion Biomedica Corp、Asahi Kasei Medical）
・結論

Market Analysis and Insights: Global ICU-acquired Acute Kidney Treatment Market
The global ICU-acquired Acute Kidney Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ICU-acquired Acute Kidney Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ICU-acquired Acute Kidney Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ICU-acquired Acute Kidney Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ICU-acquired Acute Kidney Treatment market.

Global ICU-acquired Acute Kidney Treatment Scope and Market Size
ICU-acquired Acute Kidney Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global ICU-acquired Acute Kidney Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pre-renal
Intrinsic-renal
Post-renal

Segment by Application
Public Hospital
Private Hospital

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Quark Pharmaceuticals
Fresenius Medical Care
B. Braun
Baxter international
Angion Biomedica Corp
Asahi Kasei Medical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pre-renal
1.2.3 Intrinsic-renal
1.2.4 Post-renal
1.3 Market by Application
1.3.1 Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global ICU-acquired Acute Kidney Treatment Market Perspective (2016-2027)
2.2 ICU-acquired Acute Kidney Treatment Growth Trends by Regions
2.2.1 ICU-acquired Acute Kidney Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 ICU-acquired Acute Kidney Treatment Historic Market Share by Regions (2016-2021)
2.2.3 ICU-acquired Acute Kidney Treatment Forecasted Market Size by Regions (2022-2027)
2.3 ICU-acquired Acute Kidney Treatment Industry Dynamic
2.3.1 ICU-acquired Acute Kidney Treatment Market Trends
2.3.2 ICU-acquired Acute Kidney Treatment Market Drivers
2.3.3 ICU-acquired Acute Kidney Treatment Market Challenges
2.3.4 ICU-acquired Acute Kidney Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue
3.1.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue (2016-2021)
3.1.2 Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Players (2016-2021)
3.2 Global ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by ICU-acquired Acute Kidney Treatment Revenue
3.4 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio
3.4.1 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ICU-acquired Acute Kidney Treatment Revenue in 2020
3.5 ICU-acquired Acute Kidney Treatment Key Players Head office and Area Served
3.6 Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service
3.7 Date of Enter into ICU-acquired Acute Kidney Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 ICU-acquired Acute Kidney Treatment Breakdown Data by Type
4.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Type (2016-2021)
4.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2022-2027)

5 ICU-acquired Acute Kidney Treatment Breakdown Data by Application
5.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Application (2016-2021)
5.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America ICU-acquired Acute Kidney Treatment Market Size (2016-2027)
6.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type
6.2.1 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021)
6.2.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027)
6.2.3 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2027)
6.3 North America ICU-acquired Acute Kidney Treatment Market Size by Application
6.3.1 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021)
6.3.2 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027)
6.3.3 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2027)
6.4 North America ICU-acquired Acute Kidney Treatment Market Size by Country
6.4.1 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021)
6.4.2 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe ICU-acquired Acute Kidney Treatment Market Size (2016-2027)
7.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type
7.2.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021)
7.2.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027)
7.2.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2027)
7.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Application
7.3.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021)
7.3.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027)
7.3.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2027)
7.4 Europe ICU-acquired Acute Kidney Treatment Market Size by Country
7.4.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021)
7.4.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size (2016-2027)
8.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type
8.2.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application
8.3.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region
8.4.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America ICU-acquired Acute Kidney Treatment Market Size (2016-2027)
9.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type
9.2.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021)
9.2.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027)
9.2.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2027)
9.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application
9.3.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021)
9.3.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027)
9.3.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2027)
9.4 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country
9.4.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021)
9.4.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size (2016-2027)
10.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type
10.2.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application
10.3.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country
10.4.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Quark Pharmaceuticals
11.1.1 Quark Pharmaceuticals Company Details
11.1.2 Quark Pharmaceuticals Business Overview
11.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Introduction
11.1.4 Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021)
11.1.5 Quark Pharmaceuticals Recent Development
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Details
11.2.2 Fresenius Medical Care Business Overview
11.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Introduction
11.2.4 Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021)
11.2.5 Fresenius Medical Care Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Details
11.3.2 B. Braun Business Overview
11.3.3 B. Braun ICU-acquired Acute Kidney Treatment Introduction
11.3.4 B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021)
11.3.5 B. Braun Recent Development
11.4 Baxter international
11.4.1 Baxter international Company Details
11.4.2 Baxter international Business Overview
11.4.3 Baxter international ICU-acquired Acute Kidney Treatment Introduction
11.4.4 Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021)
11.4.5 Baxter international Recent Development
11.5 Angion Biomedica Corp
11.5.1 Angion Biomedica Corp Company Details
11.5.2 Angion Biomedica Corp Business Overview
11.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Introduction
11.5.4 Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021)
11.5.5 Angion Biomedica Corp Recent Development
11.6 Asahi Kasei Medical
11.6.1 Asahi Kasei Medical Company Details
11.6.2 Asahi Kasei Medical Business Overview
11.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Introduction
11.6.4 Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021)
11.6.5 Asahi Kasei Medical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pre-renal
Table 3. Key Players of Intrinsic-renal
Table 4. Key Players of Post-renal
Table 5. Global ICU-acquired Acute Kidney Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global ICU-acquired Acute Kidney Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global ICU-acquired Acute Kidney Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global ICU-acquired Acute Kidney Treatment Market Share by Regions (2016-2021)
Table 9. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global ICU-acquired Acute Kidney Treatment Market Share by Regions (2022-2027)
Table 11. ICU-acquired Acute Kidney Treatment Market Trends
Table 12. ICU-acquired Acute Kidney Treatment Market Drivers
Table 13. ICU-acquired Acute Kidney Treatment Market Challenges
Table 14. ICU-acquired Acute Kidney Treatment Market Restraints
Table 15. Global ICU-acquired Acute Kidney Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global ICU-acquired Acute Kidney Treatment Market Share by Players (2016-2021)
Table 17. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2020)
Table 18. Ranking of Global Top ICU-acquired Acute Kidney Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by ICU-acquired Acute Kidney Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service
Table 22. Date of Enter into ICU-acquired Acute Kidney Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global ICU-acquired Acute Kidney Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Quark Pharmaceuticals Company Details
Table 63. Quark Pharmaceuticals Business Overview
Table 64. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Product
Table 65. Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021) & (US$ Million)
Table 66. Quark Pharmaceuticals Recent Development
Table 67. Fresenius Medical Care Company Details
Table 68. Fresenius Medical Care Business Overview
Table 69. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Product
Table 70. Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021) & (US$ Million)
Table 71. Fresenius Medical Care Recent Development
Table 72. B. Braun Company Details
Table 73. B. Braun Business Overview
Table 74. B. Braun ICU-acquired Acute Kidney Treatment Product
Table 75. B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021) & (US$ Million)
Table 76. B. Braun Recent Development
Table 77. Baxter international Company Details
Table 78. Baxter international Business Overview
Table 79. Baxter international ICU-acquired Acute Kidney Treatment Product
Table 80. Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021) & (US$ Million)
Table 81. Baxter international Recent Development
Table 82. Angion Biomedica Corp Company Details
Table 83. Angion Biomedica Corp Business Overview
Table 84. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Product
Table 85. Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021) & (US$ Million)
Table 86. Angion Biomedica Corp Recent Development
Table 87. Asahi Kasei Medical Company Details
Table 88. Asahi Kasei Medical Business Overview
Table 89. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Product
Table 90. Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2016-2021) & (US$ Million)
Table 91. Asahi Kasei Medical Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ICU-acquired Acute Kidney Treatment Market Share by Type: 2020 VS 2027
Figure 2. Pre-renal Features
Figure 3. Intrinsic-renal Features
Figure 4. Post-renal Features
Figure 5. Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2020 VS 2027
Figure 6. Public Hospital Case Studies
Figure 7. Private Hospital Case Studies
Figure 8. ICU-acquired Acute Kidney Treatment Report Years Considered
Figure 9. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global ICU-acquired Acute Kidney Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global ICU-acquired Acute Kidney Treatment Market Share by Regions (2022-2027)
Figure 13. Global ICU-acquired Acute Kidney Treatment Market Share by Players in 2020
Figure 14. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2020
Figure 16. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America ICU-acquired Acute Kidney Treatment Market Share by Type (2016-2027)
Figure 20. North America ICU-acquired Acute Kidney Treatment Market Share by Application (2016-2027)
Figure 21. North America ICU-acquired Acute Kidney Treatment Market Share by Country (2016-2027)
Figure 22. United States ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe ICU-acquired Acute Kidney Treatment Market Share by Type (2016-2027)
Figure 26. Europe ICU-acquired Acute Kidney Treatment Market Share by Application (2016-2027)
Figure 27. Europe ICU-acquired Acute Kidney Treatment Market Share by Country (2016-2027)
Figure 28. Germany ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Region (2016-2027)
Figure 38. China ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America ICU-acquired Acute Kidney Treatment Market Share by Type (2016-2027)
Figure 46. Latin America ICU-acquired Acute Kidney Treatment Market Share by Application (2016-2027)
Figure 47. Latin America ICU-acquired Acute Kidney Treatment Market Share by Country (2016-2027)
Figure 48. Mexico ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Country (2016-2027)
Figure 54. Turkey ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Quark Pharmaceuticals Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2016-2021)
Figure 58. Fresenius Medical Care Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2016-2021)
Figure 59. B. Braun Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2016-2021)
Figure 60. Baxter international Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2016-2021)
Figure 61. Angion Biomedica Corp Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2016-2021)
Figure 62. Asahi Kasei Medical Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Acquired Cystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3750 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、後天性嚢胞性腎疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、その他）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ...

世界の急性腎障害治療市場規模・現状・予測（2021年-2027年）

Global Acute Kidney Injury Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3757 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、急性腎障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（前腎性急性腎障害、後腎性急性腎障害、内在性腎性急性腎障害）、用途別市場規模（病院、外来外科センター、その他）、主要地域別市場規模（北米、ア...

世界の急性腎障害治療法市場規模・現状・予測（2021年-2027年）

Global Acute Kidney Injury Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5566 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、急性腎障害治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非薬物式、薬物式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の後天性血友病治療市場規模・現状・予測（2021年-2027年）

Global Acquired Hemophilia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3751 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、後天性血友病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（伝統療法、高度療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の多発性嚢胞腎治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Kidney Disease Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4730 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多発性嚢胞腎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ANG-3070、CIM-2、CR-8、その他）、用途別市場規模（常染色体優性多発性嚢胞腎（ADPKD）、常染色体劣性多発性嚢胞腎（A...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の急性興奮・攻撃性治療市場規模・現状・予測（2021年-2027年）

Global Acute Agitation and Aggression Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5060 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、急性興奮・攻撃性治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、筋肉内注射、その他）、用途別市場規模（病院＆外来手術室、精神科医療施設、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年）

Global Kidney/Renal Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4404 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓/腎線維化治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンジオテンシンII受容体拮抗薬（ARB）、アンジオテンシン変換酵素（ACE）阻害薬、ピルフェニドン、レニン阻害薬、バソペプチダーゼ阻...

世界の常染色体優性多発性嚢胞腎用治療市場規模・現状・予測（2021年-2027年）

Global Autosomal Dominant Polycystic Kidney Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3879 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、常染色体優性多発性嚢胞腎用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（痛み＆炎症治療、腎臓結石治療、尿路感染症治療、腎不全治療、その他）、用途別市場規模（病院、診療所、外来手術センター、その他...

世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年）

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3756 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デラフロキサシン、バンコマイシン、セフタロリンフォサミル、その他）、用途別市場規模（蜂巣炎、膿瘍、外科...

世界の急性腎障害治療市場規模・現状・予測（2021年-2027年） Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure. Market Analysis and Insights: Global Acute Kidney Injury Treatment Market The global Acute Kidney Injury Treatment market size is projected to r…
世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年） Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure. Market Analysis and Insights: Global Kidney/…
世界の後天性嚢胞性腎疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Cystic Kidney Disease Treatment Drugs Market The global Acquired Cystic Kidney Disease Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年） Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women. Market Analysis and Insights: Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market The glo…
世界の急性腎障害治療法市場規模・現状・予測（2021年-2027年） Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as…